VIVO - Meridian Bioscience Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Catalyst watch: DraftKings, PepsiCo, Asana, AbbVie and Walgreens in focus
• Meridian Bioscience Non-GAAP EPS of $0.16 misses by $0.01, revenue of $67.8M beats by $1M
• FDA re-authorizes emergency use approval for Meridian's Revogene COVID-19 test
• Meridian Bioscience downgraded at William Blair on $1.53B acquisition
• Meridian to be acquired by SD Biosensor, SJL Partners for $1.53B
• Meridian Bioscience hits 52-week high; stock up 36% YTD
• Meridian Biosciences says its qPCR mixes can be used in monkeypox molecular tests
• Meridian Bioscience Non-GAAP EPS of $0.66 beats by $0.19, revenue of $111.23M beats by $11.68M
• Meridian acquires EUPROTEIN to expand recombinant protein capabilities
• Meridian Bioscience provides preliminary FQ2 numbers
• Meridian Bioscience rises 5% on boosted fiscal 2022 guidance
• Meridian Bioscience Non-GAAP EPS of $0.35, revenue of $88.3M
• Meridian Bioscience Q1 2022 Earnings Preview
• Meridian awarded additional NIH funding to advance development of Revogene panel
• Meridian Bioscience launches saliva-specific mixes for DNA, RNA detection
• Meridian Bioscience names new chairman
• Meridian Bioscience wins FDA clearance for Curian Campy assay
• Meridian Bioscience announces retirement of CFO
• Meridian Bioscience Chairman David Phillips retiring
• Meridian Bioscience EPS beats by $0.03, beats on revenue